<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00980863</url>
  </required_header>
  <id_info>
    <org_study_id>LQ-bip</org_study_id>
    <nct_id>NCT00980863</nct_id>
  </id_info>
  <brief_title>Effects of a Lifestyle Intervention on Body Mass Index in Patients With Bipolar Disorder</brief_title>
  <official_title>Effects of a Lifestyle Intervention on Body Mass Index in Patients With Bipolar Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with bipolar disorder are at increased risk of weight gain, which in turn, increases&#xD;
      the risk for somatic disease and non-adherence to maintenance therapy. Therefore,&#xD;
      interventions addressing weight gain are expedient for the management of this disorder. The&#xD;
      investigators set out to evaluate the effects of a lifestyle intervention on body mass index,&#xD;
      cardiovascular, glycemic and metabolic parameters in patients with bipolar disorder under&#xD;
      mood stabilizing pharmacological treatment. 50 outpatients with bipolar disorder under mood&#xD;
      stabilizing treatment participated in a randomized controlled trial (waiting control group&#xD;
      N=24 and multimodal lifestyle intervention N=26). Each experimental group consisted of two&#xD;
      cohorts. The intervention lasted five months and consisted of eleven group sessions and&#xD;
      weekly fitness training. Body Mass Index (BMI), body weight as well as cardiovascular,&#xD;
      glycemic and metabolic parameters were determined as baseline (March and September 2005) and&#xD;
      after five (July 2005 and January 2006) and eleven months (January and July 2006).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">August 2006</completion_date>
  <primary_completion_date type="Actual">August 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BMI</measure>
    <time_frame>11 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>Lifestyle intervention to increase physical activity</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>waiting control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>lifestyle intervention to increase physical activity</intervention_name>
    <arm_group_label>Lifestyle intervention to increase physical activity</arm_group_label>
    <arm_group_label>waiting control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults between 18 and 70 years of age were considered for inclusion if they:&#xD;
&#xD;
               1. fulfilled the diagnostic criteria for bipolar disorder according to DSM-IV-TR,27;&#xD;
&#xD;
               2. were on treatment with medication for at least three months with one of the&#xD;
                  following substances: lithium, valproic acid carbamazepine, oxcarbazepine,&#xD;
                  olanzapine, quetiapine, risperidone, amisulpride; and&#xD;
&#xD;
               3. were not underweight (BMI &gt; 20 kg/m2).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Actual breast feeding&#xD;
&#xD;
          -  A diagnosis of anorexia nervosa or bulimia nervosa&#xD;
&#xD;
          -  Diabetes type I or II or another serious physical disease&#xD;
&#xD;
          -  Use of substances that reduce weight (e.g., topiramate, lamotrigine as mood stabilizer&#xD;
             in monotherapy)&#xD;
&#xD;
          -  Participants with comorbidity of acute psychosis, drug addiction, personality&#xD;
             disorder, suicidal tendencies or a current severe manic or depressive episode were&#xD;
             excluded only if attending the program was not possible due to the respective disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Waldemar Greil, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanatorium Kilchberg, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanatorium Kilchberg</name>
      <address>
        <city>Zuerich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <study_first_submitted>September 18, 2009</study_first_submitted>
  <study_first_submitted_qc>September 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2009</study_first_posted>
  <last_update_submitted>September 18, 2009</last_update_submitted>
  <last_update_submitted_qc>September 18, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Waldemar Greil</name_title>
    <organization>Privatklinik Sanatorium Kilchberg</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

